Jinqi You

Sun Yat-sen University — China

Immunology and Microbiology · Life Sciences

6h-index344citations11works9.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(4), Cancer Immunotherapy and Biomarkers(3), Immune cells in cancer(3), Pancreatic and Hepatic Oncology Research(2), Immunotherapy and Immune Responses(2)

Publications11 total

The CXCL10‐CXCR3 Axis Induces Tumor‐Associated Neutrophils to Interfere with CTLs‐Mediated Antitumor Activity in EBV‐Associated Epithelial Cancers
Advanced Science·2025· 1 citedOpen Access
Enhancing CAR-T Cell Metabolic Fitness and Memory Phenotype for Improved Efficacy against Hepatocellular Carcinoma
International Journal of Biological Sciences·2025· 5 citedOpen Access
Tumor vascular endothelial cells promote immune escape by upregulating PD-L1 expression via crosstalk between NF-κB and STAT3 signaling pathways in nasopharyngeal carcinoma
Cell Death and Disease·2025· 10 citedOpen Access
Transformable Tumor Microenvironment‐Responsive Oxygen Vacancy‐Rich MnO <sub>2</sub> @Hydroxyapatite Nanospheres for Highly Efficient Cancer Sonodynamic Immunotherapy
Advanced Science·2025· 11 citedOpen Access
TLS and immune cell profiling: immunomodulatory effects of immunochemotherapy on tumor microenvironment in resectable stage III NSCLC
Frontiers in Immunology·2024· 5 citedOpen Access
Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese population
BMC Cancer·2024· 3 citedOpen Access
EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion
Journal for ImmunoTherapy of Cancer·2024· 28 citedOpen Access
Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma
BMC Medicine·2023· 34 citedOpen Access
BMP9‐induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus‐associated hepatocellular carcinoma
Clinical and Translational Medicine·2023· 4 citedOpen Access
Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer
OncoImmunology·2021· 119 citedOpen Access
The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors
Molecular Cancer·2020· 124 citedOpen Access

Frequent Co-authors

Tong Xiang(7), Dijun Ouyang(6), Jian‐Chuan Xia(6), Songzuo Xie(5), Chaopin Yang(4), Qiuzhong Pan(4), Yan Tang(4), Yuanyuan Chen(4), Jingjing Zhao(4), Hao Chen(4), Xinyi Yang(4), Desheng Weng(4), Yizhi Wang(3), Desheng Weng(3), Minxing Li(3), Yuanyuan Liu(3), Ze-Rui Zhao(2), Si Chen(2), Hao Long(2), Xinyi Yang(2)